Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Amylyx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amylyx Pharmaceuticals Inc
Rating: 1.49975
Author: Trendlyne DVM scores

about

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

11.99 0.61 (5.36%)

29.30% Fall from 52W High

1.4M

XNAS Volume

XNAS 07 Jan, 2026 4:00 PM (EST)

Not Eligible

Expensive Valuation

7.0 / 100

Technically Neutral

53.0 / 100

1Yr Price target upside is 69%

9 analysts

Amylyx Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

29.30% Fall from 52W High

SWOT Analysis

Amylyx Pharma Inc Live Price Chart